Figure 5.
Accumulated incidence of grade ≥2 late toxicity among Conv EBRT, HDEBRT, and HDR boost groups. (a) Accumulated incidence of grade ≥2 gastrointestinal (GI) toxicity. (b) Accumulated incidence of grade ≥2 genitourinary (GU) toxicity.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.